Technology Hardware and Equipment

Switzerland Psi Researchers Tender

📄 Tender ID: 466615718 📅 Published: 20 Oct 2021

📋 Tender Overview

Researchers working at the Paul Scherrer Institute PSI have identified a chemical compound that impedes the multiplication of single-cell parasites such as the pathogens that cause malaria and toxoplasmosis. Pending additional lab testing a drug could be developed on this basis.A new active agent against parasites has been discovered at the Paul Scherrer Institute PSI. According to a press release issued by the PSI two of its researchers borrowed a principle that has long been successfully used in chemotherapy. This involves administering substances to block the protein tubulin in cancer cells which is effective as tubulin is key to cell division. Ashwani Sharma and Natacha Gaillard from the Laboratory of Biomolecular Research have now expanded this principle in applying it to single-cell parasites.To achieve this the researchers had to decipher the molecular structure of tubulin in certain single-cell parasites known as apicomplexa. This group of single-celled eukaryotic parasites includes the pathogens that cause malaria and toxoplasmosis. To successfully decipher the molecular structure of the protein the researchers used the Swiss Light Source SLS housed at the PSI and electron microscopy. They then searched for and found the chemical compound capable of inhibiting the protein. They named this parabulin.Tests carried out by the PSIs cooperation partner the University of California found that the parasite was practically incapable of reproducing in the presence of parabulin. In contrast parabulin had virtually no effect on human cells. That is a good sign Ashwani Sharma says adding that The substance apparently acts only on the tubulin of the parasite a basic requirement to be able to use it as a drug against infectious diseases. The research findings were published on Monday in the journal EMBO Molecular Medicine.The PSI has now submitted a patent application and is planning to conduct further tests with parabulin in lab settings. Thereafter the aim will be to further develop the chemical compound into a drug with the help of the pharmaceutical industry.

🔍 Key Information

📄
Tender Reference No.
466615718
📅
Publication Date
20 Oct 2021
🌐
Sector
Technology Hardware and Equipment
📝
Notice Type
News
📍
Location
Switzerland

📁 Documents & Downloads

No documents found

🏷️ CPV

No CPV found

Need help with this bid?

Our bid experts can help you find, evaluate & win more tenders.

🎧 Talk to Bid Expert
🕒 Submission deadline
0
days remaining · 20 Oct 2021
🔔 Set Alert

🧭 Quick Facts

Authority N/A
Country Switzerland
State / UT N/A
Tender Type Procurement News
Currency N/A
Similar Tenders
Loading similar tenders…